Noval, Baby Girl .

HRN: 26-61-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2025
CEFUROXIME 750MG (VIAL)
07/28/2025
08/03/2025
IVT
240mg
Q8
Pneumonia
Remove - Pending Acceptance
07/29/2025
CEFUROXIME 750MG (VIAL)
07/29/2025
08/04/2025
IV
250mg
Q8h
PCAP C
Remove - Pending Acceptance
08/01/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/01/2025
08/07/2025
IVT
50mg
Q12
PCAP-C
Remove - Pending Acceptance
08/03/2025
CEFTRIAXONE 1G (VIAL)
08/03/2025
08/09/2025
IV
75mg
Once A Day
Acute Gastroenteritis
Remove - Pending Acceptance
08/03/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/03/2025
08/09/2025
TOPICAL
Apply Thinly
2 Times A Day
Cellulitis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: